Stellanova Therapeutics

About:

Stellanova Therapeutics is a private, development-stage biotechnology company that focuses on cancer therapies

Website: https://stellanovatx.com

Top Investors: Sporos Bioventures

Description:

Stellanova Therapeutics is a private, development-stage biotechnology company in Houston Texas advancing therapies targeting the tumor microenvironment to treat cancers resistant to current therapies. The company’s platform centers on a drug pipeline targeting cancer-associated fibroblasts that spur tumors, an approach which has, to date, shown unprecedented anti-tumor activity in multiple resistant cancer models

Total Funding Amount:

$15.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Houston, Texas, United States

Founded Date:

2019-01-01

Founders:

Ronald A. DePinho, Rosa F. Hwang

Number of Employees:

1-10

Last Funding Date:

2021-06-03

IPO Status:

Private

Industries:

© 2025 bioDAO.ai